Loblaw Shares Surge as Earnings Exceed Expectations, Plans Four-for-One Stock Split
ByAinvest
Thursday, Jul 24, 2025 12:03 pm ET1min read
MORN--
The company's performance was driven by increased same-store traffic, basket size, and item count. Same-store sales at food and retail climbed by 5.4%, while drug pharmacy and healthcare same-store sales jumped by 6.2%. In its drug retail operations, same-store sales increased by 4.1%, and front same-store sales edged up by 1.7% [1].
In addition to the strong earnings report, Loblaw announced a four-for-one stock split. The stock split will be implemented by way of a stock dividend, with each shareholder receiving three additional shares for each share held. The stock split will be effective at the close of business on August 18, 2025, for shareholders of record at the close of business on August 14, 2025 [2]. The stock split aims to enhance accessibility and liquidity for investors and employees, without diluting shareholders' equity [2].
Analysts have a strong consensus rating on Loblaw's stock, with a Strong Buy rating and a C$241.12 price target, implying a 9.94% upside potential [1].
References:
[1] https://www.morningstar.com/news/dow-jones/202507244628/loblaw-revenue-profit-rise-as-same-store-traffic-climbs
[2] https://www.newswire.ca/news-releases/loblaw-companies-limited-announces-four-for-one-stock-split-847712105.html
TSE--
Loblaw's Q3 earnings report exceeded expectations, with $714 million in earnings, up from $457 million in Q2 2024. Revenue also increased to $14.7 billion, up from $13.9 billion. The company announced a four-for-one stock split to enhance accessibility and liquidity for investors and employees. Analysts have a Strong Buy consensus rating on TSE:L stock with a C$241.12 price target, implying 9.94% upside potential.
Loblaw Companies Limited reported strong Q3 earnings, with revenue and profit rising significantly compared to the previous quarter. The company's earnings available to common shareholders surged by 60.1% to C$2.37 per share, while adjusted earnings came in at C$2.40 per share, surpassing analysts' expectations of C$2.33 per share [1]. Revenue increased by 5.2% to C$14.67 billion, slightly above analysts' projections of C$14.63 billion [1].The company's performance was driven by increased same-store traffic, basket size, and item count. Same-store sales at food and retail climbed by 5.4%, while drug pharmacy and healthcare same-store sales jumped by 6.2%. In its drug retail operations, same-store sales increased by 4.1%, and front same-store sales edged up by 1.7% [1].
In addition to the strong earnings report, Loblaw announced a four-for-one stock split. The stock split will be implemented by way of a stock dividend, with each shareholder receiving three additional shares for each share held. The stock split will be effective at the close of business on August 18, 2025, for shareholders of record at the close of business on August 14, 2025 [2]. The stock split aims to enhance accessibility and liquidity for investors and employees, without diluting shareholders' equity [2].
Analysts have a strong consensus rating on Loblaw's stock, with a Strong Buy rating and a C$241.12 price target, implying a 9.94% upside potential [1].
References:
[1] https://www.morningstar.com/news/dow-jones/202507244628/loblaw-revenue-profit-rise-as-same-store-traffic-climbs
[2] https://www.newswire.ca/news-releases/loblaw-companies-limited-announces-four-for-one-stock-split-847712105.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet